Literature DB >> 9358975

Pathophysiology of central nervous system complications in diabetes mellitus.

A D Mooradian1.   

Abstract

It is now generally accepted that diabetes can alter central nervous system (CNS) function. Even in the absence of overt cerebrovascular accidents or repeated hypoglycemic reactions, uncontrolled hyperglycemia is associated with cognitive changes. These changes are documented both in patients with diabetes as well as in animal models of experimental diabetes. The cognitive impairment can be ameliorated with optimization of blood glucose control. The potential causes of CNS dysfunction in diabetes can be broadly categorized as either vascular causes including changes in the blood-brain barrier and metabolic changes. The latter causes include repeated hypoglycemic episodes, hyperglycemia, hyperosmolality, acidosis, ketosis, neuroendocrine or neurochemical changes. The other contributory causes of CNS dysfunction in diabetes include the presence of hypertension, uremia, peripheral and autonomic neuropathy and multiple drug use.

Entities:  

Mesh:

Year:  1997        PMID: 9358975

Source DB:  PubMed          Journal:  Clin Neurosci        ISSN: 1065-6766


  11 in total

Review 1.  Human cerebral neuropathology of Type 2 diabetes mellitus.

Authors:  Peter T Nelson; Charles D Smith; Erin A Abner; Frederick A Schmitt; Stephen W Scheff; Gregory J Davis; Jeffrey N Keller; Gregory A Jicha; Daron Davis; Wang Wang-Xia; Adria Hartman; Douglas G Katz; William R Markesbery
Journal:  Biochim Biophys Acta       Date:  2008-08-22

2.  Diabetes Mellitus and Blood-Brain Barrier Dysfunction: An Overview.

Authors:  Shikha Prasad; Ravi K Sajja; Pooja Naik; Luca Cucullo
Journal:  J Pharmacovigil       Date:  2014-06

3.  Reduced gap junctional communication among astrocytes in experimental diabetes: contributions of altered connexin protein levels and oxidative-nitrosative modifications.

Authors:  Kelly K Ball; Lamia Harik; Gautam K Gandhi; Nancy F Cruz; Gerald A Dienel
Journal:  J Neurosci Res       Date:  2011-05-02       Impact factor: 4.164

4.  Diabetes-related changes in rat cerebral occludin and zonula occludens-1 (ZO-1) expression.

Authors:  Joe M Chehade; Michael J Haas; Arshag D Mooradian
Journal:  Neurochem Res       Date:  2002-03       Impact factor: 3.996

5.  Combined effects of hyperglycemic conditions and HIV-1 Nef: a potential model for induced HIV neuropathogenesis.

Authors:  Edward A Acheampong; Cassandra Roschel; Muhammad Mukhtar; Alagarsamy Srinivasan; Mohammad Rafi; Roger J Pomerantz; Zahida Parveen
Journal:  Virol J       Date:  2009-10-30       Impact factor: 4.099

6.  Hyperglycaemia and diabetes impair gap junctional communication among astrocytes.

Authors:  Gautam K Gandhi; Kelly K Ball; Nancy F Cruz; Gerald A Dienel
Journal:  ASN Neuro       Date:  2010-03-15       Impact factor: 4.146

Review 7.  Evidence-Based Management of Diabetes in Older Adults.

Authors:  Arshag D Mooradian
Journal:  Drugs Aging       Date:  2018-12       Impact factor: 3.923

8.  Glycogen synthase kinase-3 regulates production of amyloid-β peptides and tau phosphorylation in diabetic rat brain.

Authors:  Zhong-Sen Qu; Liang Li; Xiao-Jiang Sun; Yu-Wu Zhao; Jin Zhang; Zhi Geng; Jian-Liang Fu; Qing-Guo Ren
Journal:  ScientificWorldJournal       Date:  2014-04-03

9.  Neuroprotection of Gueichih-Fuling-Wan on cerebral ischemia/ reperfusion injury in streptozotocin-induced hyperglycemic rats via the inhibition of the cellular apoptosis pathway and neuroinflammation.

Authors:  Yuh-Fung Chen; Kuo-Jen Wu; Wei-Shih Huang; Yow-Wen Hsieh; Yu-Wen Wang; Huei-Yann Tsai; Ming-Ming Lee
Journal:  Biomedicine (Taipei)       Date:  2016-11-14

Review 10.  The Effect of Diabetes Mellitus on Apoptosis in Hippocampus: Cellular and Molecular Aspects.

Authors:  Akram Sadeghi; Javad Hami; Shahnaz Razavi; Ebrahim Esfandiary; Zahra Hejazi
Journal:  Int J Prev Med       Date:  2016-03-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.